ACADIA PHARMACEUTICALS INC's ticker is and the CUSIP is 004225908. A total of 1 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,713,000 | -14.8% | 145,200 | -26.6% | 0.01% | -28.6% |
| Q1 2016 | $5,533,000 | +4.9% | 197,900 | +33.8% | 0.01% | +16.7% |
| Q4 2015 | $5,273,000 | +69.8% | 147,900 | +57.5% | 0.01% | +100.0% |
| Q3 2015 | $3,105,000 | -41.1% | 93,900 | -25.4% | 0.00% | -40.0% |
| Q2 2015 | $5,273,000 | -13.1% | 125,900 | -32.3% | 0.01% | -16.7% |
| Q1 2015 | $6,065,000 | +29.5% | 186,100 | +26.2% | 0.01% | +20.0% |
| Q4 2014 | $4,683,000 | +22.4% | 147,500 | -4.5% | 0.01% | +25.0% |
| Q3 2014 | $3,825,000 | +33.4% | 154,500 | +21.7% | 0.00% | +33.3% |
| Q2 2014 | $2,867,000 | -28.7% | 126,900 | -23.2% | 0.00% | -40.0% |
| Q1 2014 | $4,022,000 | +32.7% | 165,300 | +36.3% | 0.01% | +25.0% |
| Q4 2013 | $3,031,000 | +37.2% | 121,300 | +50.9% | 0.00% | +33.3% |
| Q3 2013 | $2,209,000 | +38.0% | 80,400 | -8.8% | 0.00% | 0.0% |
| Q2 2013 | $1,601,000 | – | 88,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 200,000 | $2,818,000 | 0.16% |
| SIMPLEX TRADING, LLC | 124,300 | $1,751,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 67,800 | $955,000 | 0.00% |
| JANE STREET GROUP, LLC | 102,600 | $1,446,000 | 0.00% |
| JPMORGAN CHASE & CO | 102,700 | $1,447,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |